What is the treatment for recurrent aphthous ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Recurrent Aphthous Ulcers

Start with high-potency topical corticosteroids (clobetasol 0.05% gel or betamethasone 0.5mg/10ml rinse) applied 2-4 times daily as first-line therapy, combined with topical anesthetics for pain control before meals. 1

First-Line Topical Management

Topical Corticosteroids (primary treatment):

  • For localized ulcers: Apply clobetasol gel or ointment 0.05% directly to dried ulcer 2-4 times daily 1
  • For multiple or widespread ulcers: Use betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water as rinse-and-spit solution 2-4 times daily 1
  • Alternative: Triamcinolone acetonide 0.1% paste applied directly to dried ulcer 2-4 times daily 1

Pain Control (use concurrently):

  • Apply viscous lidocaine 2% before meals 1
  • Use benzydamine hydrochloride rinse or spray every 3 hours, particularly before eating 1
  • Consider amlexanox 5% oral paste for severe pain 1, 2

Barrier Protection:

  • Apply mucoprotectant mouthwashes (e.g., Gelclair) three times daily 1
  • Use white soft paraffin ointment to lips every 2 hours 1

Oral Hygiene Protocol

  • Clean mouth daily with warm saline mouthwashes 1
  • Use antiseptic oral rinses twice daily (1.5% hydrogen peroxide or 0.2% chlorhexidine digluconate) 1
  • For dry mouth, recommend sugarless chewing gum, candy, or salivary substitutes 1

Second-Line Management for Refractory Cases

When topical therapy fails after 1-2 weeks 1:

  • Intralesional steroids: Inject triamcinolone weekly (total dose 28 mg) for persistent localized ulcers 1
  • Systemic corticosteroids: Use prednisone/prednisolone 30-60 mg or 1 mg/kg for 1 week with tapering over the second week for highly symptomatic or recurrent ulcers 1

Third-Line Systemic Therapy for Recurrent Disease

For patients with ≥4 episodes per year 1:

  • Colchicine is the preferred first-line systemic agent, especially effective when erythema nodosum or genital ulcers are present 1, 3
  • For resistant cases, consider in order:
    • Azathioprine 1
    • Interferon-alpha 1
    • TNF-alpha inhibitors (infliximab or adalimumab) 1
    • Apremilast 1

Critical Pitfalls to Avoid

  • Do not taper corticosteroids prematurely before disease control is established 1
  • Do not continue same treatment if ulcers persist beyond 2 weeks without response 1
  • Avoid sodium lauryl sulfate-containing toothpastes, hard/acidic/salty foods, alcohol, and carbonated drinks 4

When to Refer or Investigate Further

  • Refer to specialist for ulcers lasting more than 2 weeks or not responding to 1-2 weeks of treatment 1
  • Consider biopsy for ulcers lasting over 2 weeks or not responding to treatment to exclude malignancy 1
  • Perform blood tests (full blood count, coagulation, fasting glucose, HIV antibody, syphilis serology) before biopsy to exclude contraindications and identify underlying causes 1

Evidence Quality Note

The strongest evidence supports topical corticosteroids as cornerstone therapy 1. While multiple topical agents have been studied, triamcinolone acetonide 0.1% and amlexanox 5% demonstrated statistically significant efficacy in reducing ulcer size, number, pain, erythema and exudate levels compared to placebo 2. Systemic therapies are supported by lower quality evidence but are reasonable for severe refractory cases 1, 4.

References

Guideline

Management of Oral Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Aphthous ulcers and oral ulcerations].

Presse medicale (Paris, France : 1983), 2016

Research

The treatment of chronic recurrent oral aphthous ulcers.

Deutsches Arzteblatt international, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.